Trend in approval of targeted biologics in the last two decades
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2024.
Autor principal: | Siddika, Khadiza |
---|---|
Altres autors: | Ahmed, Syeda Maliha |
Format: | Thesis |
Idioma: | English |
Publicat: |
Brac University
2024
|
Matèries: | |
Accés en línia: | http://hdl.handle.net/10361/24296 |
Ítems similars
-
Targeted therapeutic options in the treatment of Breast Cancer
per: Alam, Kazi Tasnuva
Publicat: (2022) -
Study on anticancer drugs approved by the FDA from 2014 to 2023
per: Rattry, Faria Rahman
Publicat: (2024) -
Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
per: Tania, Umme
Publicat: (2023) -
RIPK pathway, as a potential target, for cancer treatment - a review
per: Jahan, Nusrat
Publicat: (2024) -
Molecular biology : genes to proteins /
per: Tropp, Burton E.
Publicat: (2008)